We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 15, 2022

Prognostic Relevance of Quantitative and Longitudinal MOG Antibody Testing in Patients With MOGAD

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study
J. Neurol. Neurosurg. Psychiatr. 2022 Dec 02;[EPub Ahead of Print], M Gastaldi, T Foiadelli, G Greco, S Scaranzin, E Rigoni, S Masciocchi, S Ferrari, C Mancinelli, L Brambilla, M Mancardi, T Giacomini, D Ferraro, M Della Corte, A Gallo, M Di Filippo, L Benedetti, G Novi, M Versino, P Banfi, R Iorio, L Moiola, E Turco, S Sartori, M Nosadini, M Ruggieri, S Savasta, E Colombo, E Ballante, S Jarius, S Mariotto, D Franciotta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading